1 |
Hallatt JG, Steele CH Jr, Snyder M. Ruptured corpus luteum with hemoperitoneum: a study of 173 surgical cases. Am J Obstet Gynecol 1984;149:5-9.
DOI
|
2 |
Castro-Lizano N, Calleja C, Galindo-Rodriguez G, Avina-Zubieta JA. Ovarian haemorrhage, rupture and haemoperitoneum secondary to thrombocy-topenia in a patient with SLE. Lupus 2003;12:648-650.
DOI
ScienceOn
|
3 |
Hahn BH. Systemic lupus erythematosus. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill, 2005:1960-1967.
|
4 |
Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol 1997;24:867-870.
|
5 |
Wallace DJ. Severe lupus. In: Hochberg MC, Silman AJ, Weisman MH, Weinblatt ME, Smolen JS, eds. Rheumatology. 3rd ed. Edinburgh: Mosby, 2003:1419-1425.
|
6 |
Karpatkin S. Autoimmune thrombocytopenic purpura. Semin Hematol 1985;22:260-288.
|
7 |
The American College of Rheumatology nomenclat-ure and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
DOI
ScienceOn
|
8 |
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
|
9 |
Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005;64:620-625.
DOI
ScienceOn
|
10 |
Boumpas DT, Barez S, Klippel JH, Balow JE. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1990;112:674-677.
DOI
ScienceOn
|